Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:JUNS

Jupiter Neurosciences (JUNS) Stock Price, News & Analysis

Jupiter Neurosciences logo

About Jupiter Neurosciences Stock (NASDAQ:JUNS)

Key Stats

Today's Range
$1.38
$1.67
50-Day Range
N/A
52-Week Range
N/A
Volume
486,767 shs
Average Volume
140,895 shs
Market Capitalization
$55.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Jupiter Neurosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
3rd Percentile Overall Score

JUNS MarketRank™: 

Jupiter Neurosciences scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Jupiter Neurosciences are expected to decrease in the coming year, from ($0.06) to ($0.11) per share.

  • Price to Book Value per Share Ratio

    Jupiter Neurosciences has a P/B Ratio of 12.23. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.28% of the float of Jupiter Neurosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Jupiter Neurosciences has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • Dividend Yield

    Jupiter Neurosciences does not currently pay a dividend.

  • Dividend Growth

    Jupiter Neurosciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.28% of the float of Jupiter Neurosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Jupiter Neurosciences has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • News Coverage This Week

    MarketBeat has tracked 1 news article for Jupiter Neurosciences this week, compared to 1 article on an average week.
  • Search Interest

    Only 2 people have searched for JUNS on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
Receive JUNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Jupiter Neurosciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

JUNS Stock News Headlines

The Hidden “AI Royalty” Play
Most investors are chasing AI stocks like NVIDIA… but they're missing out on an under-the-radar opportunity. This $20 stock is at the center of AI's explosive energy demand—and it's paying out 270X more in "AI Royalties" than NVIDIA.tc pixel
See More Headlines

JUNS Stock Analysis - Frequently Asked Questions

Jupiter Neurosciences, Inc. (NASDAQ:JUNS) issued its quarterly earnings results on Monday, August, 18th. The company reported ($0.07) EPS for the quarter, hitting the consensus estimate of ($0.07).

Jupiter Neurosciences (JUNS) raised $11 million in an IPO on Tuesday, December 3rd 2024. The company issued 2,800,000 shares at a price of $4.00 per share. Dominari Securities and Revere Securities acted as the underwriters for the IPO.

Company Calendar

Last Earnings
8/18/2025
Today
9/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
N/A
Current Symbol
NASDAQ:JUNS
CIK
1679628
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.44 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-835.24%
Return on Assets
-155.10%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.07
Quick Ratio
1.07

Sales & Book Value

Annual Sales
$230 thousand
Price / Sales
240.78
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.13 per share
Price / Book
12.23

Miscellaneous

Outstanding Shares
34,830,000
Free Float
N/A
Market Cap
$55.38 million
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:JUNS) was last updated on 9/29/2025 by MarketBeat.com Staff
From Our Partners